Says will tell "the whole story" about Q4 in Q4 earnings report. Comments taken from JPMorgan Healthcare Conference.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on EW:
- Edwards Lifesciences price target lowered to $73 from $78 at Canaccord
- Edwards Lifesciences price target lowered to $92 from $99 at Citi
- Edwards Lifesciences price target lowered to $92 from $98 at Morgan Stanley
- Edwards Lifesciences to host investor meeting
- Edwards Lifesciences backs FY22 adjusted EPS view $2.40-$2.50, consensus $2.46
Questions or Comments about the article? Write to editor@tipranks.com